Manassas, Virginia, January 2022. Stromatis Pharma announced that Walter Olesiak, Operating Partner at Remiges Ventures, has joined the Stromatis Pharma Board of Directors. Walter has over 28 years of experience in business development, healthcare consulting, and venture investment. In addition to Remiges Ventures, Walter spent 12 years in venture investments with Mitsui Ventures. He held positions as a board member or observer in 10 portfolio companies during that time. Before Mitsui, Walter spent six years with Cambridge Pharma Consultancy (an IMS Health company), advising global pharmaceutical pricing, reimbursement, and market access issues to lead pharmaceutical and biotechnology companies. Before Cambridge, Walter spent eight years in Tokyo in various roles with Genzyme Japan and SRL, Inc. Walter holds an AB in Biochemical Sciences from Harvard University and MBA from Cornell University.
“Walter’s experience and expertise make him the perfect addition to the Stromatis Pharma Board of Directors, “ said Stromatis Pharma Board Co-Chairperson Guy Yachin. Stromatis Pharma is a private biotech company located in Prince William County’s Innovation Park, Manassas, VA. Stromatis Pharma is committed to developing therapeutics for patients with difficult-to-treat cancers. The team at Stromatis Pharma is devoted to the mission of creating a portfolio of superior and highly specific immunotherapies.
Stromatis Pharma Contact:
Guy Yachin, MBA
(301) 633-0393
guy.yachin@gmail.com
Source: Stromatis Pharma, Inc.
